Loading clinical trials...
Loading clinical trials...
Efficacy of Neoadjuvant XELOX/AVASTIN Therapy for Nonresectable Colorectal Liver Metastases With Secondary Hepatic Resection/Radiofrequency
Conditions
Interventions
bevacizumab
capecitabine
+4 more
Locations
1
United States
University of California Davis Cancer Center
Sacramento, California, United States
Start Date
June 1, 2007
Primary Completion Date
April 1, 2008
Completion Date
April 1, 2008
Last Updated
June 9, 2017
NCT06696768
NCT04704661
NCT05489211
NCT06625775
NCT04657068
NCT06445062
Lead Sponsor
University of California, Davis
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions